Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Bruker
BRKR
$8.83B
| $4.21M | ﹤0.01% |
100,863
+12,777
| +15% | +$665K |
|
2027
OGE Energy
OGE
$9.71B
| $4.21M | ﹤0.01% |
91,534
-62,152
| -40% | -$2.7M |
|
2028
PUT
Goldman Sachs
GS
$304B
| $4.21M | ﹤0.01% |
7,700
-74,100
| -91% | -$44.6M |
|
2029
PUT
PACCAR
PCAR
$68.8B
| $4.21M | ﹤0.01% |
43,200
-98,800
| -70% | -$10.4M |
|
2030
ICU Medical
ICUI
$4.58B
| $4.2M | ﹤0.01% |
30,235
-19,846
| -40% | -$3.08M |
|
|
GMS
2031
DELISTED
GMS Inc
GMS
| $4.18M | ﹤0.01% |
57,192
-15,013
| -21% | -$1.2M |
|
|
APLS
2032
DELISTED
Apellis Pharmaceuticals
APLS
| $4.18M | ﹤0.01% |
191,237
+31,672
| +20% | +$875K |
|
2033
Sunrun
RUN
$2.37B
| $4.18M | ﹤0.01% |
713,242
+69,987
| +11% | +$576K |
|
2034
Cimpress
CMPR
$2.37B
| $4.18M | ﹤0.01% |
92,399
+7,655
| +9% | +$430K |
|
2035
Vericel Corp
VCEL
$2.28B
| $4.17M | ﹤0.01% |
93,503
-16,543
| -15% | -$890K |
|
2036
PUT
Viasat
VSAT
$11.4B
| $4.17M | ﹤0.01% |
400,000
+393,900
| +6,457% | +$3.8M |
|
2037
Privia Health
PRVA
$2.78B
| $4.17M | ﹤0.01% |
185,597
-34,643
| -16% | -$805K |
|
2038
First American
FAF
$7.56B
| $4.16M | ﹤0.01% |
63,459
-34,547
| -35% | -$2.19M |
|
2039
Veeco
VECO
$3.28B
| $4.15M | ﹤0.01% |
206,698
+33,821
| +20% | +$810K |
|
2040
FTI Consulting
FCN
$4.24B
| $4.14M | ﹤0.01% |
25,247
-6,500
| -20% | -$1.17M |
|
2041
WaFd
WAFD
$2.81B
| $4.14M | ﹤0.01% |
144,701
-26,557
| -16% | -$788K |
|
|
DNB
2042
DELISTED
Dun & Bradstreet
DNB
| $4.13M | ﹤0.01% |
461,787
+278,122
| +151% | +$2.85M |
|
2043
Acadia Pharmaceuticals
ACAD
$4.89B
| $4.13M | ﹤0.01% |
248,448
-49,997
| -17% | -$908K |
|
2044
Driven Brands
DRVN
$2.12B
| $4.11M | ﹤0.01% |
240,015
-22,355
| -9% | -$366K |
|
2045
PUT
Zillow
Z
$8.08B
| $4.11M | ﹤0.01% |
60,000
+10,000
| +20% | +$764K |
|
2046
RingCentral
RNG
$5.66B
| $4.1M | ﹤0.01% |
165,719
+81,292
| +96% | +$2.54M |
|
2047
Veracyte
VCYT
$3.42B
| $4.1M | ﹤0.01% |
138,372
-16,966
| -11% | -$647K |
|
2048
CorVel
CRVL
$3.25B
| $4.09M | ﹤0.01% |
36,491
-12,918
| -26% | -$1.44M |
|
2049
Hecla Mining
HL
$11.9B
| $4.07M | ﹤0.01% |
731,442
-285,461
| -28% | -$1.58M |
|
2050
Stantec
STN
$8.44B
| $4.06M | ﹤0.01% |
49,060
+7,129
| +17% | +$570K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.